Wild C, Weiderpass E, Stewart BW. Pancreatic cancer, world cancer report: cancer research for cancer prevention. Lyon: World Health Organization; 2020. p. 367–73.
Google Scholar
Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–21.
Article
CAS
PubMed
Google Scholar
Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, et al. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318–48.
Article
PubMed
PubMed Central
Google Scholar
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607–20.
Article
PubMed
PubMed Central
Google Scholar
Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388:73–85.
Article
CAS
PubMed
Google Scholar
Urrutia G, Salmonson A, Toro-Zapata J, de Assuncao TM, Mathison A, Dusetti N, et al. Combined targeting of g9a and checkpoint kinase 1 synergistically inhibits pancreatic cancer cell growth by replication fork collapse. Mol Cancer Res. 2020;18:448–62.
Article
CAS
PubMed
Google Scholar
Mukhija D, Nagpal SJS, Sohal DPS. Epidemiology, tumor characteristics, and survival in patients with primary pancreatic lymphoma: a large population-based study using the seer database. Am J Clin Oncol. 2019;42:454–8.
Article
PubMed
Google Scholar
Zheng SM, Zhou DJ, Chen YH, Jiang R, Wang YX, Zhang Y, et al. Pancreatic T/histiocyte-rich large B-cell lymphoma: a case report and review of literature. World J Gastroenterol. 2017;23:4467–72.
Article
PubMed
PubMed Central
Google Scholar
Sadot E, Yahalom J, Do RK, Teruya-Feldstein J, Allen PJ, Gonen M, et al. Clinical features and outcome of primary pancreatic lymphoma. Ann Surg Oncol. 2015;22:1176–84.
Article
PubMed
Google Scholar
Khashab M, Mokadem M, DeWitt J, Emerson R, Sherman S, LeBlanc J, et al. Endoscopic ultrasound-guided fine-needle aspiration with or without flow cytometry for the diagnosis of primary pancreatic lymphoma—a case series. Endoscopy. 2010;42:228–31.
Article
CAS
PubMed
Google Scholar
Savari O, Al-Duwal Z, Wang Z, Ganesan S, Danan-Rayes R, Ayub S. Pancreatic lymphoma: a cytologic diagnosis challenge. Diagn Cytopathol. 2020;48:350–5.
Article
PubMed
Google Scholar
Huang Z, Li M, He D, Wei Y, Yu H, Wang Y, et al. Two-dimensional texture analysis based on CT images to differentiate pancreatic lymphoma and pancreatic adenocarcinoma: a preliminary study. Acad Radiol. 2019;26:e189–95.
Article
PubMed
Google Scholar
Kurashige J, Yokobori T, Mima K, Sawada G, Takahashi Y, Ueo H, et al. Plastin3 is associated with epithelial–mesenchymal transition and poor prognosis in gastric cancer. Oncol Lett. 2019;17:2393–9.
CAS
PubMed
Google Scholar
Xin Z, Li D, Mao F, Du Y, Wang X, Xu P, et al. PLS3 predicts poor prognosis in pancreatic cancer and promotes cancer cell proliferation via PI3K/AKT signaling. J Cell Physiol. 2020;235(11):8416–23.
Article
CAS
PubMed
Google Scholar
Kujawski R, Przybyłowska-Sygut K, Mik M, Lewandowski M, Trzciński R, Berut M, et al. Expression of the pls3 gene in circulating cells in patients with colorectal cancer. Pol Przegl Chir. 2015;87:59–64.
PubMed
Google Scholar
Velthaus A, Cornils K, Hennigs JK, Grub S, Stamm H, Wicklein D, et al. The actin binding protein plastin-3 is involved in the pathogenesis of acute myeloid leukemia. Cancers. 2019;11:1663.
Article
CAS
PubMed Central
Google Scholar
Ueo H, Sugimachi K, Gorges TM, Bartkowiak K, Yokobori T, Muller V, et al. Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer. Br J Cancer. 2015;112:1519–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yokobori T, Iinuma H, Shimamura T, Imoto S, Sugimachi K, Ishii H, et al. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial–mesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res. 2013;73:2059–69.
Article
CAS
PubMed
Google Scholar
Szkandera J, Winder T, Stotz M, Weissmueller M, Langsenlehner T, Pichler M, et al. A common gene variant in PLS3 predicts colon cancer recurrence in women. Tumour Biol. 2013;34:2183–8.
Article
CAS
PubMed
Google Scholar
Shaul YD, Yuan B, Thiru P, Nutter-Upham A, McCallum S, Lanzkron C, et al. MERAV: a tool for comparing gene expression across human tissues and cell types. Nucleic Acids Res. 2016;44:D560–6.
Article
CAS
PubMed
Google Scholar
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.
Article
PubMed
PubMed Central
CAS
Google Scholar
Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28:882–3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Walter W, Sanchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31:2912–4.
Article
CAS
PubMed
Google Scholar
Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531:47–52.
Article
CAS
PubMed
Google Scholar
Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77.
Article
Google Scholar
Hornick JL, Lauwers GY, Odze RD. Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver. Am J Surg Pathol. 2005;29:381–9.
Article
PubMed
Google Scholar
Huo Z, Zhai S, Weng Y, Qian H, Tang X, Shi Y, et al. PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis. Onco Targets Ther. 2019;12:5037–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ma YY, Shi JJ, Chen JB, Xu KC, Niu LZ. Irreversible electroporation for liver metastasis from pancreatic cancer: a case report. World J Clin Cases. 2020;8:390–7.
Article
PubMed
PubMed Central
Google Scholar
Fritscher-Ravens A. Endoscopic ultrasound evaluation in the diagnosis and staging of lung cancer. Lung Cancer. 2003;41:259–67.
Article
PubMed
Google Scholar
Kim J, Bamlet WR, Oberg AL, Chaffee KG, Donahue G, Cao XJ, et al. Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19–9 blood markers. Sci Transl Med. 2017. https://doi.org/10.1126/scitranslmed.aah5583.
Article
PubMed
PubMed Central
Google Scholar
Cohen JD, Javed AA, Thoburn C, Wong F, Tie J, Gibbs P, et al. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. Proc Natl Acad Sci USA. 2017;114:10202–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mellby LD, Nyberg AP, Johansen JS, Wingren C, Nordestgaard BG, Bojesen SE, et al. Serum biomarker signature-based liquid biopsy for diagnosis of early-stage pancreatic cancer. J Clin Oncol. 2018;36:2887–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fan X, Alekseyenko AV, Wu J, Peters BA, Jacobs EJ, Gapstur SM, et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case–control study. Gut. 2018;67:120–7.
Article
CAS
PubMed
Google Scholar
Sharma A, Smyrk TC, Levy MJ, Topazian MA, Chari ST. Fasting blood glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis. Gastroenterology. 2018;155:490-500.e2.
Article
CAS
PubMed
Google Scholar
Sharma A, Kandlakunta H, Nagpal SJS, Feng Z, Hoos W, Petersen GM, et al. Model to determine risk of pancreatic cancer in patients with new-onset diabetes. Gastroenterology. 2018;155:730-739.e3.
Article
PubMed
Google Scholar
Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. New Engl J Med. 2014;371:1039–49.
Article
CAS
PubMed
Google Scholar
Yau D, Aron M, Siddiqi IN. Diffuse large B-cell lymphoma with striking intrasinusoidal pseudoglandular growth pattern as a diagnostic dilemma mimicking metastatic poorly differentiated pancreatic adenocarcinoma in an intraabdominal lymph node. Int J Surg Pathol. 2019;27:181–4.
Article
PubMed
Google Scholar
Constantin A, Tănase AD, Săftoiu A, Copăescu C. A primary retroperitoneal diffuse large b-cell lymphoma: a challenging diagnosis. Curr Health Sci J. 2018;44:392–6.
CAS
PubMed
PubMed Central
Google Scholar
Ravindhran B, Prakash C, Govindharaj S, Bahnou NMS, Pavithra B. An aggressive primary retroperitoneal diffuse large B-cell lymphoma mimicking a pancreatic neoplasm, presenting as duodenal stenosis. J Clin Diagn Res. 2017;11:pd09-pd11.
PubMed
PubMed Central
Google Scholar
Neureiter D, Zopf S, Dimmler A, Stintzing S, Hahn EG, Kirchner T, et al. Different capabilities of morphological pattern formation and its association with the expression of differentiation markers in a xenograft model of human pancreatic cancer cell lines. Pancreatology. 2005;5:387–97.
Article
CAS
PubMed
Google Scholar
Chang CH, Yen MC, Liao SH, Hsu YL, Lai CS, Chang KP, et al. Secreted protein acidic and rich in cysteine (SPARC) enhances cell proliferation, migration, and epithelial mesenchymal transition, and SPARC expression is associated with tumor grade in head and neck cancer. Int J Mol Sci. 2017;18:1556.
Article
CAS
PubMed Central
Google Scholar
Wan S, Meyer AS, Weiler SME, Rupp C, Toth M, Sticht C, et al. Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasiveness. Hepatology. 2018;67:1842–56.
Article
CAS
PubMed
Google Scholar
Sun W, Feng J, Yi Q, Xu X, Chen Y, Tang L. SPARC acts as a mediator of TGF-beta1 in promoting epithelial-to-mesenchymal transition in A549 and H1299 lung cancer cells. BioFactors. 2018;44:453–64.
Article
CAS
PubMed
Google Scholar
Song SZ, Lin S, Liu JN, Zhang MB, Du YT, Zhang DD, et al. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial–mesenchymal transition through inhibition of the PI3K/AKT signaling pathway. J Cell Physiol. 2019;234:18587–601.
Article
CAS
PubMed
Google Scholar
Shi F, Ma Y, Qian Y, Wang Y, Wang Z, Zhao M, et al. A novel peptide probe for identification of PLS3-expressed cancer cells. Anal Chem. 2019;91:9640–7.
Article
CAS
PubMed
Google Scholar
Markiewicz A, Topa J, Nagel A, Skokowski J, Seroczynska B, Stokowy T, et al. Spectrum of epithelial–mesenchymal transition phenotypes in circulating tumour cells from early breast cancer patients. Cancers. 2019;11:59.
Article
CAS
PubMed Central
Google Scholar